444 related articles for article (PubMed ID: 31248849)
41. Comparing the Outcomes of Stereotactic Ablative Radiotherapy and Non-Stereotactic Ablative Radiotherapy Definitive Radiotherapy Approaches to Thoracic Malignancy: A Systematic Review and Meta-Analysis.
Hegi F; D'Souza M; Azzi M; De Ruysscher D
Clin Lung Cancer; 2018 May; 19(3):199-212. PubMed ID: 29370978
[TBL] [Abstract][Full Text] [Related]
42. First UK patient cohort treated with stereotactic ablative radiotherapy for primary kidney cancer.
Zarkar A; Henderson D; Carver A; Heyes G; Harrop V; Tutill S; Kilkenny J; Marshall A; Elbeltagi N; Howard H
BJUI Compass; 2023 Jul; 4(4):464-472. PubMed ID: 37334027
[TBL] [Abstract][Full Text] [Related]
43. Radiosurgery for Treatment of Renal Cell Metastases to Spine: A Systematic Review of the Literature.
Smith BW; Joseph JR; Saadeh YS; La Marca F; Szerlip NJ; Schermerhorn TC; Spratt DE; Younge KC; Park P
World Neurosurg; 2018 Jan; 109():e502-e509. PubMed ID: 29038086
[TBL] [Abstract][Full Text] [Related]
44. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
Carrasco-Esteban E; Barrionuevo-Castillo P; Domínguez-Rullán J; Gómez-Aparicio MA; Ferri-Molina M; Sáez-Bueno P; Zalabarría-Zarrabeitia Z; Scorsetti M; Arcangeli S; López-Campos F; Couñago F
Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):163-176. PubMed ID: 36443137
[TBL] [Abstract][Full Text] [Related]
45. Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus.
Hannan R; Margulis V; Chun SG; Cannon N; Kim DW; Abdulrahman RE; Sagalowsky A; Pedrosa I; Choy H; Brugarolas J; Timmerman RD
Cancer Biol Ther; 2015; 16(5):657-61. PubMed ID: 25800036
[TBL] [Abstract][Full Text] [Related]
46. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
[TBL] [Abstract][Full Text] [Related]
47. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials.
Ghia AJ; Chang EL; Bishop AJ; Pan HY; Boehling NS; Amini B; Allen PK; Li J; Rhines LD; Tannir NM; Tatsui CE; Brown PD; Yang JN
J Neurosurg Spine; 2016 May; 24(5):829-36. PubMed ID: 26799117
[TBL] [Abstract][Full Text] [Related]
48. Stereotactic body radiation therapy for primary renal cell carcinoma: A review on behalf of the CC-AFU.
Bentahila R; Bensalah K; Benziane-Ouaritini N; Barthelemy P; Rioux-Leclerc N; Correas JM; Belhomme S; Bigot P; Sargos P
Fr J Urol; 2024 May; 34(7-8):102660. PubMed ID: 38823486
[TBL] [Abstract][Full Text] [Related]
49. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study.
Sahin B; Atalar B; Kaytan Saglam E; Akgun Z; Abacioglu U; Arifoglu A; Ozyar E; Yaprak G; Ozseker Isik N; Guney Y; Caglar HB; Karaman S; Igdem S; Selek U; Berber T; Oner Dincbas F; Sengoz M; Yucel S; Demiral AN; Akyurek S
Clin Respir J; 2020 Nov; 14(11):1050-1059. PubMed ID: 32749053
[TBL] [Abstract][Full Text] [Related]
50. Stereotactic body radiotherapy for inoperable patients with renal carcinoma.
Kotzki L; Udrescu C; Lapierre A; Badet L; Rouviere O; Paparel P; Chapet O
Fr J Urol; 2024 Mar; 34(2):102575. PubMed ID: 38364353
[TBL] [Abstract][Full Text] [Related]
51. Radiotherapy for renal cell carcinoma: renaissance of an overlooked approach.
Siva S; Kothari G; Muacevic A; Louie AV; Slotman BJ; Teh BS; Lo SS
Nat Rev Urol; 2017 Sep; 14(9):549-563. PubMed ID: 28631740
[TBL] [Abstract][Full Text] [Related]
52. Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer: A Systematic Review and Meta-analysis.
Lehrer EJ; Singh R; Wang M; Chinchilli VM; Trifiletti DM; Ost P; Siva S; Meng MB; Tchelebi L; Zaorsky NG
JAMA Oncol; 2021 Jan; 7(1):92-106. PubMed ID: 33237270
[TBL] [Abstract][Full Text] [Related]
53. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
54. Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Meta-Analysis and International Stereotactic Radiosurgery Society Practice Guidelines.
Bae SH; Chun SJ; Chung JH; Kim E; Kang JK; Jang WI; Moon JE; Roquette I; Mirabel X; Kimura T; Ueno M; Su TS; Tree AC; Guckenberger M; Lo SS; Scorsetti M; Slotman BJ; Kotecha R; Sahgal A; Louie AV; Kim MS
Int J Radiat Oncol Biol Phys; 2024 Feb; 118(2):337-351. PubMed ID: 37597757
[TBL] [Abstract][Full Text] [Related]
55. Stereotactic ablative body radiation therapy for primary kidney cancer: a 3-dimensional conformal technique associated with low rates of early toxicity.
Pham D; Thompson A; Kron T; Foroudi F; Kolsky MS; Devereux T; Lim A; Siva S
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1061-8. PubMed ID: 25442039
[TBL] [Abstract][Full Text] [Related]
56. Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy.
Ponti E; Lancia A; Ost P; Trippa F; Triggiani L; Detti B; Ingrosso G
Eur Urol Focus; 2017 Dec; 3(6):538-544. PubMed ID: 28801240
[TBL] [Abstract][Full Text] [Related]
57. A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.
Svedman C; Sandström P; Pisa P; Blomgren H; Lax I; Kälkner KM; Nilsson S; Wersäll P
Acta Oncol; 2006; 45(7):870-5. PubMed ID: 16982552
[TBL] [Abstract][Full Text] [Related]
58. Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinoma.
Ponsky L; Lo SS; Zhang Y; Schluchter M; Liu Y; Patel R; Abouassaly R; Welford S; Gulani V; Haaga JR; Machtay M; Ellis RJ
Radiother Oncol; 2015 Oct; 117(1):183-7. PubMed ID: 26362723
[TBL] [Abstract][Full Text] [Related]
59. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
60. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases.
Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U
Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]